Here Is How AI Startup Conflixis Is Protecting Hospitals from Corrupt Doctors

In the complex and high-stakes environment of healthcare, hospitals face numerous challenges in maintaining ethical practices and managing financial risks. Conflixis, an AI-powered compliance startup, offers a solution tailored to hospitals, aiming to mitigate corruption by identifying conflicts of interest between healthcare providers and industry vendors. Founded by Aaron Narva and Joseph Bergen, Conflixis combines AI-driven analytics with expertise in investigative work to revolutionize healthcare compliance.

Background: The Birth of Conflixis

After a successful career investigating compliance and financial risks with global firms like Kroll, FTI Consulting, and Exiger, Aaron Narva noticed that hospitals face similar challenges as financial institutions regarding conflicts of interest and regulatory risks. During his tenure at Exiger, Narva acquired experience with AI tools that uncovered risks in public records and tracked corruption in business relationships. He realized that similar principles could benefit hospitals, where relationships with pharmaceutical companies and device manufacturers often create potential conflicts of interest. Narva saw an opportunity to apply his expertise to healthcare, laying the foundation for Conflixis.

The Problem: Unchecked Conflicts in Healthcare

Corruption risks in healthcare often stem from interactions between doctors and commercial interests, such as drug companies or medical device manufacturers. Physicians who receive financial incentives, consulting fees, or sponsored grants from these companies may unintentionally prioritize certain treatments or products, possibly affecting patient care. Despite government databases like OpenPaymentsData.com, which tracks these conflicts, merely disclosing such relationships doesn’t solve the issue. Federal laws, including the Stark Law and the Anti-Kickback Statute (AKS), seek to curb such conflicts, but hospitals struggle to manage these vast, intricate networks without advanced tools.

How Conflixis Identifies Risk in Medical Relationships

Conflixis uses advanced AI algorithms to detect conflicts that could pose financial or legal risks for hospitals. By analyzing data from multiple sources — including OpenPaymentsData.com, hospital procurement data, claims data, and patient outcome records — the AI engine identifies the relationships that require further investigation. Narva explains, “A large health system might have 200,000 relationships with vendors. Conflixis helps identify which ones carry significant risks.”

This precision is what makes Conflixis powerful. By narrowing down thousands of connections to just a few high-risk ones, hospitals can address compliance issues effectively, minimizing the resources required for risk assessment.

Preventing Unnecessary Expenditures Through Data Insight

Beyond identifying conflicts of interest, Conflixis aids hospitals in cost management. The AI system highlights situations where spending could be linked to biased recommendations, helping hospitals avoid purchasing costly equipment when there are more affordable, equally effective options. By providing insight into these high-stakes purchasing decisions, Conflixis enhances transparency and encourages more rational, data-driven decisions.

The Confluxis Advantage: Combining AI with Investigative Expertise

In a competitive market with established health compliance solutions like Compliatric and Symplr, Conflixis sets itself apart through its unique blend of AI technology and investigative expertise. Instead of relying solely on standard machine learning models, Conflixis modified off-the-shelf algorithms with tailored methodologies inspired by Narva’s background in transaction monitoring and corruption investigations. This customization enables Conflixis to detect patterns specific to healthcare that may otherwise go unnoticed.

The Road Ahead: Growth and Investment

Founded in 2023, Conflixis quickly gained traction, securing a $4.2 million seed investment led by Lerer Hippeau and Origin Ventures, with participation from other notable investors like Mark VC, Springtime Ventures, and Cretiv Capital. With less than $5 million in revenue so far, Conflixis has already established a foothold in the healthcare compliance market and continues to attract new clients. Narva’s long-term vision for the company is not only to enhance healthcare transparency but also to improve operational efficiency by integrating ethical and financial considerations.

Conclusion: Building Trust in Healthcare with Conflixis

As hospitals continue to navigate an increasingly regulated landscape, Conflixis offers a timely solution. By helping healthcare providers manage conflicts of interest, reduce regulatory risks, and optimize spending, Conflixis is establishing a new standard in healthcare compliance. With its specialized approach that combines AI and investigative expertise, Conflixis promises to build a more transparent, ethical, and financially responsible healthcare system.